Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

The DDR1 receptor tyrosine kinase is activated by matrix collagens and has been implicated in numerous cellular functions such as proliferation, differentiation, adhesion, migration, and invasion. Here we report the discovery of a potent and selective DDR1 inhibitor, DDR1-IN-1, and present the 2.2 Å...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Kim, H, Tan, L, Weisberg, E, Liu, F, Canning, P, Choi, H, Ezell, SA, Wu, H, Zhao, Z, Wang, J, Mandinova, A, Griffin, J, Bullock, A, Liu, Q, Lee, S, Gray, N
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2013

Παρόμοια τεκμήρια

Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor.
ανά: Kim, H, κ.ά.
Έκδοση: (2014)

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors
ανά: Canning, P, κ.ά.
Έκδοση: (2014)

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
ανά: Canning, P, κ.ά.
Έκδοση: (2014)

Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum
ανά: Maria G. Nava, κ.ά.
Έκδοση: (2023-02-01)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
ανά: López-Ramos, M, κ.ά.
Έκδοση: (2010)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
ανά: López-Ramos, M, κ.ά.
Έκδοση: (2010)

Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation
ανά: William A. Denny, κ.ά.
Έκδοση: (2021-11-01)

Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment
ανά: Panupong Mahalapbutr, κ.ά.
Έκδοση: (2024-02-01)

Discovery of Novel Naphthoquinone–Chalcone Hybrids as Potent FGFR1 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling
ανά: Ronnakorn Leechaisit, κ.ά.
Έκδοση: (2023-08-01)

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
ανά: Patrice Dubreuil, κ.ά.
Έκδοση: (2009-09-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
ανά: Xu H, κ.ά.
Έκδοση: (2019-07-01)

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
ανά: Sudarshan R Iyer, κ.ά.
Έκδοση: (2023-10-01)

Recent Advances in Discovery of New Tyrosine Kinase Inhibitors Using Computational Methods
ανά: Vesna Rastija
Έκδοση: (2019-08-01)

Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
ανά: Chunmin Yang, κ.ά.
Έκδοση: (2022-05-01)

Small-molecule inhibitors of the c-Fes protein-tyrosine kinase.
ανά: Hellwig, S, κ.ά.
Έκδοση: (2012)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights (September, pg 3175, 2010)
ανά: Lopez-Ramos, M, κ.ά.
Έκδοση: (2011)

Kindlin-3 inactivation mediates melanoma agressiveness through crosstalk with the collagen-activated tyrosine kinase receptor DDR1
ανά: C. Reger de Moura, κ.ά.
Έκδοση: (2024-01-01)

Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells.
ανά: Ellen Weisberg, κ.ά.
Έκδοση: (2013-01-01)

First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2
ανά: Ian M. Catlett, κ.ά.
Έκδοση: (2023-01-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
ανά: Maria Dimou, κ.ά.
Έκδοση: (2014-01-01)

TYROSINE KINASE INHIBITORS AND PREGNANCY
ανά: Elisabetta Abruzzese, κ.ά.
Έκδοση: (2014-04-01)

Second-generation inhibitors of Bruton tyrosine kinase
ανά: Jingjing Wu, κ.ά.
Έκδοση: (2016-09-01)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
ανά: Cornelius Hempel, κ.ά.
Έκδοση: (2017-01-01)

Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents
ανά: Yangyang Yao, κ.ά.
Έκδοση: (2017-10-01)

Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
ανά: John J. Ryan, MD
Έκδοση: (2016-12-01)

Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?
ανά: Zhao, Z, κ.ά.
Έκδοση: (2014)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
ανά: Ainun Nizar Masbuchin, κ.ά.
Έκδοση: (2022-09-01)

Tyrosine kinase inhibitor Tofacitinib. Safety issues
ανά: G. V. Lukina, κ.ά.
Έκδοση: (2015-12-01)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
ανά: Huang JT, κ.ά.
Έκδοση: (2022-11-01)

Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
ανά: Mark C Weir, κ.ά.
Έκδοση: (2017-01-01)

miR-494 in Extracellular Vesicles as a Potent Biomarker of Chronic Myeloid Leukemia Treatment with Tyrosine Kinase Inhibitors
ανά: Tatsuki Shibuta, κ.ά.
Έκδοση: (2022-06-01)

Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity
ανά: Chris Liang, κ.ά.
Έκδοση: (2022-03-01)

Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors
ανά: Jiangnan Liu, κ.ά.
Έκδοση: (2024-03-01)

Acquired Hypothyroidism in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors
ανά: Wu J, κ.ά.
Έκδοση: (2020-09-01)

Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disorders
ανά: Muhammad Waleed Iqbal, κ.ά.
Έκδοση: (2025-01-01)

Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
ανά: Pitsiou G, κ.ά.
Έκδοση: (2014-10-01)

509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer
ανά: Matthew Walters, κ.ά.
Έκδοση: (2020-11-01)

Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma
ανά: Wei Dai, κ.ά.
Έκδοση: (2021-05-01)

Tetrahydroisoquinoline-7-carboxamide derivatives as new selective discoidin domain receptor 1 (DDR1) inhibitors
ανά: Bullock, A, κ.ά.
Έκδοση: (2017)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
ανά: Evan Pisick, κ.ά.
Έκδοση: (2004-01-01)